Overview

Study to Evaluate the Safety, Tolerability, and Efficacy of BGE-175 in Hospitalized Adults With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory Failure

Status:
Recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
The primary objectives of this study are to evaluate the safety, tolerability, and efficacy of BGE-175 in participants ≥ 50 years of age hospitalized with documented COVID-19.
Phase:
Phase 2
Details
Lead Sponsor:
BioAge Labs, Inc.